FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283168725> ?p ?o ?g. }

• W4283168725 endingPage "722" @default.
• W4283168725 startingPage "710" @default.
• W4283168725 abstract "Lorlatinib is currently the most advanced, potent and selective anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor for the treatment of ALK-positive non-small cell lung cancer in the clinic; however, diverse compound ALK mutations driving therapy resistance emerge. Here, we determine the spectrum of lorlatinib-resistant compound ALK mutations in patients, following treatment with lorlatinib, the majority of which involve ALK G1202R or I1171N/S/T. We further identify structurally diverse lorlatinib analogs that harbor differential selective profiles against G1202R versus I1171N/S/T compound ALK mutations. Structural analysis revealed increased potency against compound mutations through improved inhibition of either G1202R or I1171N/S/T mutant kinases. Overall, we propose a classification of heterogenous ALK compound mutations enabling the development of distinct therapeutic strategies for precision targeting following sequential tyrosine kinase inhibitors. Hata and colleagues identify lorlatinib analogs that overcome acquired therapy resistance to current ALK inhibitors and show their efficacy in preclinical models of non-small cell lung cancer bearing compound therapy-resistant ALK alterations." @default.
• W4283168725 created "2022-06-21" @default.
• W4283168725 creator A5009149194 @default.
• W4283168725 creator A5009318345 @default.
• W4283168725 creator A5013652949 @default.
• W4283168725 creator A5014964762 @default.
• W4283168725 creator A5023037940 @default.
• W4283168725 creator A5031081898 @default.
• W4283168725 creator A5031655475 @default.
• W4283168725 creator A5032331306 @default.
• W4283168725 creator A5034433068 @default.
• W4283168725 creator A5037214933 @default.
• W4283168725 creator A5041971186 @default.
• W4283168725 creator A5044838791 @default.
• W4283168725 creator A5061220833 @default.
• W4283168725 creator A5066436241 @default.
• W4283168725 creator A5067755945 @default.
• W4283168725 creator A5072306777 @default.
• W4283168725 creator A5072389805 @default.
• W4283168725 creator A5074705343 @default.
• W4283168725 creator A5081227348 @default.
• W4283168725 creator A5085217465 @default.
• W4283168725 creator A5087906702 @default.
• W4283168725 date "2022-06-20" @default.
• W4283168725 modified "2023-10-18" @default.
• W4283168725 title "Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer" @default.
• W4283168725 cites W2017757358 @default.
• W4283168725 cites W2024963052 @default.
• W4283168725 cites W2055402151 @default.
• W4283168725 cites W2062291041 @default.
• W4283168725 cites W2099530756 @default.
• W4283168725 cites W2104830962 @default.
• W4283168725 cites W2105699883 @default.
• W4283168725 cites W2139110945 @default.
• W4283168725 cites W2205667543 @default.
• W4283168725 cites W2482427906 @default.
• W4283168725 cites W2540525654 @default.
• W4283168725 cites W2581996620 @default.
• W4283168725 cites W2603411876 @default.
• W4283168725 cites W2624310346 @default.
• W4283168725 cites W2767072667 @default.
• W4283168725 cites W2784414491 @default.
• W4283168725 cites W2797685139 @default.
• W4283168725 cites W2800224623 @default.
• W4283168725 cites W2888120795 @default.
• W4283168725 cites W2894476389 @default.
• W4283168725 cites W2899668190 @default.
• W4283168725 cites W2908885437 @default.
• W4283168725 cites W2923683745 @default.
• W4283168725 cites W2966785785 @default.
• W4283168725 cites W2979340940 @default.
• W4283168725 cites W3022131485 @default.
• W4283168725 cites W3048441995 @default.
• W4283168725 cites W3084573408 @default.
• W4283168725 cites W3101089668 @default.
• W4283168725 cites W3129295825 @default.
• W4283168725 cites W3173160576 @default.
• W4283168725 cites W3179610562 @default.
• W4283168725 doi "https://doi.org/10.1038/s43018-022-00399-6" @default.
• W4283168725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35726063" @default.
• W4283168725 hasPublicationYear "2022" @default.
• W4283168725 type Work @default.
• W4283168725 citedByCount "16" @default.
• W4283168725 countsByYear W42831687252022 @default.
• W4283168725 countsByYear W42831687252023 @default.
• W4283168725 crossrefType "journal-article" @default.
• W4283168725 hasAuthorship W4283168725A5009149194 @default.
• W4283168725 hasAuthorship W4283168725A5009318345 @default.
• W4283168725 hasAuthorship W4283168725A5013652949 @default.
• W4283168725 hasAuthorship W4283168725A5014964762 @default.
• W4283168725 hasAuthorship W4283168725A5023037940 @default.
• W4283168725 hasAuthorship W4283168725A5031081898 @default.
• W4283168725 hasAuthorship W4283168725A5031655475 @default.
• W4283168725 hasAuthorship W4283168725A5032331306 @default.
• W4283168725 hasAuthorship W4283168725A5034433068 @default.
• W4283168725 hasAuthorship W4283168725A5037214933 @default.
• W4283168725 hasAuthorship W4283168725A5041971186 @default.
• W4283168725 hasAuthorship W4283168725A5044838791 @default.
• W4283168725 hasAuthorship W4283168725A5061220833 @default.
• W4283168725 hasAuthorship W4283168725A5066436241 @default.
• W4283168725 hasAuthorship W4283168725A5067755945 @default.
• W4283168725 hasAuthorship W4283168725A5072306777 @default.
• W4283168725 hasAuthorship W4283168725A5072389805 @default.
• W4283168725 hasAuthorship W4283168725A5074705343 @default.
• W4283168725 hasAuthorship W4283168725A5081227348 @default.
• W4283168725 hasAuthorship W4283168725A5085217465 @default.
• W4283168725 hasAuthorship W4283168725A5087906702 @default.
• W4283168725 hasBestOaLocation W42831687252 @default.
• W4283168725 hasConcept C104317684 @default.
• W4283168725 hasConcept C117643217 @default.
• W4283168725 hasConcept C121608353 @default.
• W4283168725 hasConcept C126322002 @default.
• W4283168725 hasConcept C143065580 @default.
• W4283168725 hasConcept C184235292 @default.
• W4283168725 hasConcept C2776232967 @default.
• W4283168725 hasConcept C2776256026 @default.
• W4283168725 hasConcept C2778347629 @default.
• W4283168725 hasConcept C2778820342 @default.

• next